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The Study of Oligonucleotide Synthesis Using RNA Llgase
Peblo Leon
SUiBtlsaSiSSk
RNA llgase from bacteriophage T-4 infected Eacherichi/^oli catalyses 
the ATP-dependent formation of a 3 v5* phoaphodiastar bond batwaan an 
accaptor nuclei*acid, containing a 3*-hydroxyl group, and a donor molecule, 
containing a 5f phosphate (1). The reaction may be either intramolecular 
(2) or intermolecular (3,4). The intermolecolar reaction has proved 
useful for the synthesis of both rlbo (5) and deoxyrlbo (6) oligonucleotides 
of defined sequence as well as the extension of the 3f (7) and 5* (8) 
termini of natural RNA molecules* The RNA ligaae reaction mechanism can 
be dissected into three distinct steps involving two known covalent 
intermediates
1) ATP + lhpA + PPi
2) E-pA + pXn E [ A-59 pp5 ’ -XJ
3) EU-S'ppS'-Xj + Y ^ Y ^ X *  + pA *f E
\
In the first step RNA llgase reacts with ATP to form a covalent adenylated 
enzyme intermediate with the release of pyrophosphate. This reaction can 
occur in the absence of acceptor and donor and the adenylated ensyma can be 
discharged by the addition of pyrophosphate to reform ATP (9). The second 
step involves the transfer of the 5' AMP from adenyl llgase to the 5* 
phosphate of the donor, forming an intermediate with a 59— * S' phosphounhydrldo 
bond (4). Adenylated donors Isolated from reactions or chemically synthesised 
are reactive in the last step of the reaction in the absence of ATP, 
further suggesting their role as intermediates in the mechanism (10). The
*
third and last stap involves the formation of tho phoaphodiaatar bond 
between the oligomers via the nucleophilic attack of the 3’ hydroxyl 
group of the donor with the release of AMP (11),
The reveraal of all three steps of the RNA ligase aachanlsa hap been . 
demonstrated. The first stap can be shown to be reversible by the exchange 
of ATP and PPi and the regeneration of ATP from ensyme-AMP and PPi (9).
The last two steps are also reversible. Studies have shown that reactions
initially containing (Ap)jCp and AMP with the formation of A-S’ppS'-Cp
*
demonstrate that RNA ligase has the ability to cleave a 3f~>59 phosphoedlestar 
bond and form a pyrophosphate linkage between AMP and a 5* phosphate (12) e 
Reversal of the second step has been demonstrated under similar reaction 
conditions by isolation of ligase adenylate from reactions containing only 
(Ap)3Cp» AMP, and deadenylate ligase (12)• This reaction presumably 
proceeds by formation of A-S'ppS'-Cp followed by hydrolysis of the 
pyrophosphate linkage and formation of the protein-AMP bond 1^2)•
The last step of the RNA ligase reaction mechanism between an adenylated 
donor oligonucleotide (Ado-5fpp5'~&NA) and an acceptor oligonucleotide 
is ATP independent* Beta substituted ADP derivatives (Ado-5*pp5*-X), 
compounds analagous to the adenylated donor, react with RNA ligase and a 
RNA acceptor by transferlng their p-X portion to the acceptor with the 
formation of a phosphodlester bond and elimination of AMP (13)*
RNA ligase requires at least a 3*,5'-blsphosphate to serve as a donor*
The donor binding site probably does not extend beyond the Initial 5*-pNp 
region of the donor because the rates of reaction of a homologous series 
of pA||p donors with a given acceptor are very similar (14) * The minimal
■ 'mt+ ' ' ' '
«'it« of an oligonucleotide which will always serve aa an acceptor la a
9
trinuclaoside dlphoaphata (14,13). Acceptors containing acre than three 
residues do not show a draaatlc Increase In rates or yields suggesting 
that the acceptor site probably recognises three nucleosides and two 
phosphates.
. «e|}ws . ■ ./ A r
Matariala and Mathoda
Mav.rialat Tha aadlua salt of pAp, Ado, dAdo, (pdA)s, (pdA)4, <pA>5 , .tWN, 
NAD+ vara purchaaad fron P-L Bioch«aicala, Inc. Nicotinamide was purchased
C
from Baker, Inc. (4(n)-3H) nicotinamide adenine dinucleotide was purchased 
from Ameraham/Ssstle Corp* The sodium salt of dA4rA was a gift from 
Molecular Genetics, Inc a dA^A was algo prepared by tha method daacrlbad 
by Hinton and Gumport, Creatine-phosphoklnaae, adanylata kinase and ATP 
were purchased from Sigma Chemical Company# Spleen-phoaphodiestarase, 
snake venom phosphodiesterase and bacterial alkallni phosphatase C (EAPC) 
were obtained from Worthington Biochemical Corp# DB-81, Whatman no# 1 and 
3MM paper were obtained from Whatman, Inc# DEAE~Sephadex A-25 was purchased 
from Pharmacia, Inc• Octedecyl-sllicA filters, Bondelute C18 was obtained 
from Analytlchem International, Inc* Aero disc filters were purchased from 
Gelman, Inc. HPLC and reverse phase C-8 and C~18 columns were purchased 
from Beckman, Inc* DNase-free RNA llgase was purified from £• Colic cells 
infected with T-4 as described by McCoy at al*, 1979 (16).
Descending Chromatography Systems: > following solvents were used for
descending chromatography: (I) JLMNH4CH3CO2-95X : C2H5OH (70:30);
(It) I-C3H7OH : concentrated NH3 : water (55:10:35); and (III) 2MNH4CI In 
• 12 M sodium citrate, pH 5.8 : 95% C2H5OH (1:3), (17)* Whatman 3MM paper 
was prepared by washing with 10% CH3CO2H for 24 hours, solvent (II) for 
24 hours, and finally water for 24 hours*
Prsptrstloa of Sleeting * M t  :«m  #*€»,
by incubation *t 65*C for 2 hours in * 200 mlQroilt;er solution (0.1 
micromole of subettate) containing lOOmH Trie HCX, pH 8.0, 50mM MgCl2 
and a .2mg/ml SAPC.
Preparation of oligonucXaotidiij Acceptor 3\ S^ihydroxyl oUio^onuclapliditt 
N(pN)n and oXigodaoxyribonucleotldaa dN(pdN)a ware prepared from their 
3*-hydroxyX 3*-phosphate homologuas by incubation at 65°C for 4 hours in 
a solution (200 microliter per 0 .1 micromole of substrate) containing 
XOOttM Trls-HCl, pH 8.0, 30nM MgCXj and .lmg/ml BAFC. All 3*,5f-dihydroxyl 
oligonucleotides were purified by descending chromatography on Whatman 
3MM paper in solvent IX and desalted by drying and repeated washings with 
absolute ethanol. The product was eluted with water* As a further check 
of purity an aliquot was filtered through a 0.45 micrometer Acrodisc 
Filter, evaporated under vacuum and dissolved in 10 mlcrollters of water, 
and injected into a reverse phase C18 H?LC column. Nucleotide concentrations 
were determined by U.V» spectrophotometry using reported extinction 
coefficients (18).
8ynth.il. of dAAtAs A mixture of laM dA*, 8nM pAp, 0.4 ATP, InM 
phosphocreetln* and 2aM ap.rmlne war. dried together under vacuum. The 
reaction cocktail (100 mlcrolitam) containing SOnM Hapea buffar pH 7.9,
10 aicrograma/ml BSA, 20nM DTT, lOmM MnCl2» 170 unlta/ml myokinase, 170 
unita/ml creatine phosphokinasa and 60.4 microMoIar RNA llgasa was added 
to Initiate the reaction. The reaction was incubated at 17*C In a heated 
water bath and 4 microliter aliquots were removed for assay. The tlmapoint
V-
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aliquots wore than incubated at 65*C for 1 hour in a solution (200 mlcroliter
’■ i.
par 0.1 micromole of substrata) containing lOOtaM Tria-HCl pH 8,0, 50taM 
MgCl2 and .2mg/ml EAPC* This mixture was than deproteinlxed by dilution 
to ca. 500 microlltars with 20% (V/V) acetonitrile (HeCN) and fUtarad 
through an octadacyl-silica filter, Bondelute C18. The Bondaluta is 
first praparad by passing through 2 mis (4 x 0*5 tel) of MeOH followed 
by 2 mis (4 x 0.5 ml) of HgO. The sample is than put on the column in 20% 
HeCN and eluted with 2 ml (4 x 0,5 ml) of 20% HeCN followed by 2 ml 
(4 x 0.5 ml) of 50% HeCN. The sample was dryad down and dissolved in 10 
microliters of fyO. The sample is than injected into a reverse phase 
C-18 HPLC column and eluted at 1 ml/mln with 6% HeCN in .OIHNB^PO^ 
pH 7.0, and a decrease in 0.0. in the substrates or an increase in 0.0. in 
the suspected product is monitored. Standard solutions of dA5, dA^ and 
adenosine were used to identify substrate 0.0. peaks in the sample. All 
standard solutions were first filtered through 0.45 micrometerAcrodisc 
Filters, evaporated under vacuum and dissolved in 10 microlltars of water.
The reaction was stopped after 66 hours. The entire mixture was 
EAPC treated as described above for the timepolnts. then boiled for 2 
minutes, dryed down under vacuum and reconstituted in 50mH TEABC pH 7.5*
The reaction mixture was then partially purified on a DEAE-Saphad ex A-25 
(bicarbonate) column. The column was poured in disposable Pasteur pipettes 
approximately 3 cm tall. The sample was first eluted with 50raM followed 
bylH trlethylammonlum bicarbonate, pH 7.5. 1 ml fractions were collected
and O.D. readings taken. Fractions eluted with 1 H TEABC pH 7.5 were 
pooled dryad by evaporation under vacuum and desalted through repeated
-7-
solution and evaporation of spectral grade methanol. The sample was then 
filtered through a 0.45 micrometer Acvodisc Filterv evaporated under 
vacuum and dissolved in .01 ml of water. The resultant solution was 
injected into a reverse phase 018 HPLC column and eluted at 1 ml/min with 
6% MeCN in 0.1 M NH4H2PO4, pH 7*0* 0,5 ml fractions were collected and
OsD# monitored. Peaks were identified by spiking samples with standard 
solutions of dA4rA and dA4*
Assay of the Joining Reaction: Reactions (.01 ml!, were performed in .2 ml 
polyethylene microcentrifuge tubes in reaction mixtures containing 50 jbM 
Hepes, pH 8.3, lOmH MnCl2 or MgCl2* 20mM DTT, ,01 mg/ml BSA, 10% DH80, 
.25mH acceptor (dA5, rA5 or dA^rA) and .375mH donor, HAD 
(,108oM [4(n)-3H]NAD+ + ,266tnM NAD+) and 4.418 micromolar RNA ligaae. Tha 
reaction tubes are wrapped in parafilm, submerged in a heated water bath 
and incubated at 17*C for a total of 192 hours. 1 microliter aliquots 
were removed for assay and spotted along with markers of HAD and HKN on 
Whatman no. 1 paper and developed by descending chromatography for 12-20 
hours in solvent I ([4(n)~3H]NAD+ was checked for purity in the seme 
chromatography system). The strips w^re dried and the HAD and NMN markers 
were located under ultraviolet light. The strips were then cut into 1 cm 
pieces md counted, using a tolvene based scintillation fluid in a 
scintillation counter. The yield of products was calculated as the ratio 
of the radioactivity In the product peak to the total radioactivity on one 
strip* and was based on the limiting substrate.
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The product peak way Isolated from the Whatman no* 1 chromatograms, 
washed with 3 ml absolute ethanol to remove salts and eluted several 
times with 0.3 ml washes o£ H2O. 'the eluate was evaporated to dryness 
and prepared for BAPC treatment by Incubating the sample at 63° for 2 
hours In a solution (0.2 ml per 0 .1 micromole of substrate) containing 
Tris-HCl* pH 8.0, 50mM MgCl2, and .1 rag/ml BAPC. The reaction was stopped 
by dilution to ca. 0.5 ml with 20% (V/V). The sample was then 
deprotelnized by passing it through an octadecyl-slllca Filter1 Bondelute 
C-18 as described before. The resultant solution was evaporated under 
vacuum and redlssolved in .01 ml of water. The sample was Injected Into 
a reverse phase C-18 HPCC column and elutnd at 1 ml/mln with 5.4% MeCH in 
•01 M NH4H2PO4 pH 5.9. 0.5 fractions were collected and radioactivity in
peaks and background were quantitated using a scintillation counter.
Figure 1 shows 3 major radioactive peaks and 4 major O.D. peaks. O.D. 
peak number 4 was suspected as being product therefore it was isolated* 
concentrated and desalted on a Sephadax G~10 column (1.5 cm x 1 m) In 20% 
(V/V) ethanol* 30mM triothylammonium bicarbonate* pH 8.0 (19). An 
aliquot was put over the reverse phase C-18 HPLC column to check for purity.
Product Characterization? The peak off the Sephadex G-10 column was 
subjected to enzymatic digestion. Reactions (0.1 ml) were performed in a 
mixture containing 50mM Tris* pH 8.0* 3mM MgCl2» *05 mg/ml VPD, .1 
BAPC and the sample. The reaction was incubated at 37°C for 1 hour and 
then boiled for 2 minutes. The sample was deprotelnized by passing it 
through an ocfcadecyl-siclica filter, Bondelute C-18 as described before.
The sample was evaporated under vacuum and reconstituted in 0.02 ml of 
NaPl, pH 5.9. Standard solutions of dA» rA, Kir and a mixture of the 
three in a 4till ratio respectively were analysed by reverse phase 
HPLC column and eluted at 1 ml/min with 95 H NaPi pH 5*9 In which 
methanol was Increased from 0 to 15% for the first 20 minutes of the run* 
then at the 35 minute mark methanol was Increased further from 15 to 20% 
over 2 minutes. The runs were quantitated by integrating the areas under 
the peaks (O.D.) and normalised with calculated molar absorption 
coefficients (20). Radioactivity was determined by collecting 0.4 or 0.5 
ml fractions and assaying in a scintillation counter.
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Resulta
qAarA Synthesis? RNA ligase catalyzed the addition of pAp to the 3*- 
hydroxyl group of dA$. An At? regenerating system was need in order that 
a low but constant ATP concentration would improve the rate and yield of 
the reaction by maintaining a higher relative concentration of free 
ensyme with respect to its adenylated form (21). The DEAE-Sephadex A-25 
(bicarbonate) column was used after EAPC treatment of sample in order to 
separate the unreacted donor. Ado, from the unreacted acceptor dA^ and 
the product dA^rA. Figure 2 shows on HPLC O.D. profile of the EAPC 
treated reaction mixture before being put over a DEAE-Sephadex A-25 
column. The 3 O.D. peaks correspond to the donor, Ado, the product 
dA4rA, and the acceptor dA4 eluting off the reverse phase 018 HPLC column 
in that order. Figure 3 shows an HPLC O.D. profile of the EAPC treated 
reaction mixture after partial purification with a DEAE-Sephadex, A-25 
column. The 2 O.D. peaks correspond to the product dA4rA and the unreacted 
acceptor dA4 eluting of the 018 HPLC column in that order. The longer 
oligomer migrating faster than the shorter oligomer. This was checked 
by Injecting equimolar mixture of dA5 and dA^ into a reverse phase 018 
HPLC column using the same conditions. dAs eluted off the column before 
dA4 or the longer oligomer migrated faster than the shorter oligomer.
HPLC O.D. peaks were identified by spiking each peak with standard solutions 
of either dA^ , dA^A or Ado and observing for an Increase in the area of 
peak.
Joining Reaction (dAs. dA^rA or rA* 4* NAD4*) i Figure 4 shows ion exchange 
chromatography of t'4(n)-3H]NAD‘f of which greater than 90% of the 
radioactivity comigrated with authentic NAD4* and leas than 10% comigrated 
with authentic NMN. This control indicates the absence of any contaminating 
radioactivity which migrates as a species of greater molecular weight 
than the donor.
Incubation of a complete reaction mixture for 192 hours containing 
MgCl2» [4(n)-3H]NAD+, NA0+, and either dAs, rA5 or dA4rA with ENA ligate 
is shown as an ion exchange chromatograph in Figure 5. The reaction 
involving the acceptor dA^rA resulted in a new peak of radioactivity equivalent 
to 2 1.2% of the radioactivity transfered to the acceptor dA^A, but since 
the donor to acceptor concentration ratio was 1.5*1, this transfer represents 
a 31.8% conversion of the acceptor to product. This peak migrated slightly 
slower than the dA^A marker. The amount of trltlated NMN was about 18.5%#
The reaction Involving rA5 as the acceptor revealed at least 2 new peaks 
of radioctlvlty. The major new peak of radioactivity was equal to 16.6% 
of the radioactivity transfered to the acceptor rAj or 24.9% when correcting 
for the donor to acceptor concentration ratio. The major new radioactive 
peak migrated slower than the rA5 marker indicating a longer oligomer 
while the minor new radioactive peak migrated faster than the rA$ marker 
but slower than the NAD marker. This minor new radioactive peak was seen 
as early as 40 hours into the reaction and may represent a breakdown of 
the major radioactive product peak. The amount of trltiated NMN was 
calculated to be about 13% of the total radioactivity. The reaction involving
eh* acceptor 4Aj result** in no new radioactive peak, The aoount of 
tritiatad NMN in thle reaction accounted for 32.4% of the total radioactivity 
There appears to be gore breakdown of tritiatad HAD to tritiatad NMH in 
reactions involving thi acceptor, dA$*
Raaction Rates: 1 microliter aliquots ware removed with time to determine
the kinetics of the reaction* Figure $ shows a graph of percentage of 
radioactivity transfefed to the acceptor versus reaction time. The Figure 
demonstrates that using the acceptor rA5 produced more product than using 
the acceptor dA^rA for the first 40 hours of the raaction* At 40 hours 
breakdown of the product involving the acceptor rA5 was seen which could 
explain the decrease in rate of rA$ converted to product* The reaction 
involving the acceptor, dA^A showed no significant breakdown but the peak 
did widen during the course of the reaction so that breakdown of product 
could have occurred, without seeing breakdown paake*
Other Conditionst Substituting & 1CI2 for KgCl2 In reactions involving the 
acceptor rA5 showed decreased initial velocity gpd yield of product (Fig 9).
If MnCl2 is substituted for MgCl2 in reactions involving the acceptor 
dA^rA, a decrease in initial velocity was observed but higher yields of 
product with long reaction times were seen (Fig 10)*
Product Characterization! Figure 11 shous the elution profiles of standard 
solutions of dA, rA and Hir* The dA and rA rune each showed one major 
peak however the Hir run showed two major peaks* The slower migrating 
peak was found to be nicotinamide* Fig* 13 shows the elution profile of a
' . ti
standard solution containing dA, rA, and Nir mixed in a molar ratio of 
4s1 1 1 respectively. five major peaks vara seen with four of them 
corresponding to Nir, Nt, rA and dA and one unknown peak that eluted at 
3.75 minutes* The Mir and Mi peaks Were taken as one peak 
quantitating the areas under the peaks and normalising with calculated 
molar adsorption coefficients* The result was a molar ratio of 
3*9si.Os. 8 for dA, rA, and Mir (nir <1* Mi) respectively*
Thu product peak was treated for one hour with snake venom 
phosphocliestease and bacterial alkaline phosphatase which cleaves 
oligonucleotides to its individual nucleosides* For example the suspect 
product, dA^rANir, shovld give rise to a mixture of dA, rA and Mir in a 
4tlsl molar ratio following complete ensymatlc digestion.
The degraded product was analysed by HFLC using a 018 reverse phase 
column and runs were quantitated by integrating the areas under the peaks 
and nomalised with calculated molar adsorption coefficients (20). 
Radioactivity was determined by collecting 400 or 500 lambda fractions
and assaying in a scintillation counter. Figure; 14 shows the 0*0* elution
; •!
and radioactive profile of the product before ensymatlc degration. It 
shows one major O.D. peak eluting off the column at 20.8 minutes, with 
a corresponding radioactive peak eluting off at the same time* Two other 
minor radioactive peaks eluting at 6*5 and 12*5 minutes appear to 
correspond to elution times for Nir and Ml respectively* Another minor 
radioactive peak eluting just before the major product peak maybe 
product breakdown* Figure 15 shows the O.D. elution and radioactive
profile of the product after ensymatic degradation. The figure shove 
4 major radioactive peaks. Two of the radioactive paaks eluting at about 
5.8 minutes and 12.5 minutes appear to correspond to Nir and Ni respectively 
The other 2 major radioactive peaks eluting at about 19 end 21 minutes 
appear to correspond to partial degradation of the product and "ondagraded 
product respectively. The 0.0. profile of the degraded product contained 
many peaks that couldnot be identified. By comparing the radioactive 
profiles in Figures 14 and 15 it appears that the undegraded product was 
actually the double addition product dAarAMlrj. Partial degradation with 
VPD and BAP would result in
dApdApdApdApApNirpNir — -S-2---► *Nir + *Ni + dApdApdApdApApNir
4* undegraded product
Unfortunately thle in only speculation since the radioactivity and G*D. 
peaks couldnot be properly quantitated. This is because the O.D. and 
radioactivity peaks for the undegraded and partially degraded product 
comigrated with dA and rA nucleosides, so that possible overlap of peaks 
occureds
\
RNA llg&sa has basn used to Join singlsitrandad oligoribonucleotldes
> *
and ollgodtoxyrlbonuclsotlda* involving all three steps of the RNA ligaaa 
reaction machanism.
When j olnlng single stranded ribonucleotides to oligodeoxyriboncleotides 
the third step of the SNA ligase reaction mechanism proved successful 
under conditions of high enzyme concentrations, long reaction times, use 
of Mn& 2 instead of Mg& 2, an ATP regenerating system, incubation at 17*C 
and high donor to acceptor ratios. Although ATP is a required substate 
in this reaction, lowering its concentration while maintaining a 
concentration excess of donor ribonucleotide biophosphate over acceptor is 
said to Increase the initial velocity of the reaction (22). This effect 
can be explained in terms of the multistep mechanism of the reaction;
1) E + ATP EpA + PPi
2) EpA + pNp tfds A-5'pp5'“Np + E
3) A-5'pp3*-Np + dNoOi! dNnpMp 4 AMP
where E represents RNA ligase; EpA, adenylated ligaee (9); dN~OH the 
acceptor molecule. The final step of the sequence in which the 3^hydroxyl 
group of the acceptor displaces AMP from the adenylated donor.(A-S'ppS^tip) 
to form the product is probably rate-limiting since large quantities of 
the adenylated donor accumulate in the reaction mixvye (22). The fine! 
step requires free ensyme (11) which, in the presence of high ATP 
concentrations, would be decreased in concentration by conversion to its 
adenylated form. Thus, high ATP concentrations would inhibit the overall
reaction. Conversely, high concentrations of ATP would promote the rate- 
llmiting step by mainteining a high concentration of one of the reactants, 
the activated donor. A donort ATP: acceptor ratio of 8:0.4:1 was
therefore used to balance these ATP concentration effects (21).'A'"-" : &
When joining the mixad-compoaition oligonucleotide/dA^rA, to the 
beta substituted ADP derivative, NAD*, formation of product was observed 
under conditions of relatively low enzyme concentration, long, reaction 
times, preferential use of MnClg over MgCl2» incubation of J7°C and 
relatively low donor to acceptor ratios. The highest yield, calculated as 
the precent of donor converted to product wee 31.8%* The formation of 
NMN aa a result of the reaction between the acceptors dA/rA or rAj and the 
donor NAD* was relatively low compared to the reaction involving the 
acceptor dA5 and the donor NAD+. This observation may be due to the 
reversal of the second step of the RNA llgase reaction mechanism it* which 
NAD* and enzyme react to form NMN and adenylated enzyme, which would 
occur more readily if a poor acceptor such as dA$ is present. The reason 
for the low reactivity of DNA is not clear- The 2*-hydroxyl is probably 
not directly involved in the machanism since an oligonucleotide acceptor 
containing a terminal 2’-o-methyl group will react (23). The observation 
that formation of produce occurred using the acceptor dA^rA and not with 
the acceptor dA*, seems to confirm that addition of a single 3' terminal 
ribonucleotide to an oligodeoxyrlbonucleotide increases its reactivity (24) 
When comparing formation of product with reactions involving the acceptor 
rA5 it was found to have a higher initial reaction velocity than reactions
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involving the acceptor ciA^rA, however total yield of product using rA^ was 
less than with dA^rA. The lower product yields using rA§ in lorg reaction 
times can be explained to be due to breakdown of product. These 
observations Indicate that mixed composition molecules do not react like 
their pure DNA or RNA analogues suggesting that the enzyme prefers 
ribonucleotides in at least two of the three sub-slues of the acceptor site. 
Whether these effects are due to direct recognition of the sugar or to 
secondary conformational effects is unknown,
With long reaction times the yield of product using dA^rA was greater 
than with rAs but it appears that the product peak contained a mixture of 
products. The predominant oligonucleotide formed appears to be the double 
addition product dA^ANirNir with the minor product formed being dA^rANir. 
Multiple addition involving the donor NAD* is possible since after single 
additlonf Nlr contains a reactive 3' OH which can undergo another joining 
reaction with the donor NAD*. This can possibly be prevented by increasing 
the acceptor to donor ratio.
The use of Mn*H- instead of Mg** in reactions involving d A ^ A  and NAD* 
was found to increase yields and decrease oligomer degradation. Mn** was 
the cation used in the synthesis of dA^rA, however one complication arises 
from the Insolubility of manganese pyrophosphate after a few hours at i7°C.( 
Its precipitation results in the progressive removal of both the reaction 
product PPi and the cation. Unadenylated RNA ligase may also be 
coprecipitating with the manganese pyrophosphate.
There appears to be two major ways to Improve product yield involving
-18
reactions with d A ^ A  and NAD*. One is to increase the RNA ligase concentration 
in the reaction. This might obviate the need for long reaction times and 
thereby reduce the chances of multiple additions in reactions with high 
acceptor to donor ratios. Another method Iu tty to shift the position 
of equilibrium of the third reaction towards furination of product and 
AMP. By eliminating AMP from the tua * ton, the amount of product should be 
increased. 5*-adenylic *u td deaminase utd V  muuleotIdase can be used 
for this purpose.
Other experiments to modify the 3' ends of composite oligonucleotides 
can occur. These experiments can be used to carry out valuable biochemical 
techniques in the study of proteins and nucleic acids.
One such technique is to isolate genes. For a protein of known sequence, 
the corresponding nucleic acid sequence can be partially determined, A 
protein contains amino acids which have more than one t? h jfc codon. A 
prediction of nucleic acid sequence is based on the relative frequency of 
appearance of certain codons* Once a certain DNA sequence has been 
predicted and synthesized, a ribonucleotide and biotin, which binds tightly 
to avldln is added to the 3 '-end using RNA ligase. The synthetic DNA is 
hybridized to DNA that has been digested with restlctlon enzymes. The DNA 
would be poured down an avldln column and biotin would bind tightly to it.
The column could be used to selectively bind the DNA that is complementary 
to the biotin-modified synthesized fragments. The hybridized fragment is 
then eluted off the column, the strands separated, and the nucleic acid 
sequence of the desired fragments determined.
-19-
Modifying the 3* end cf composite oligonucleotides might be preferred 
to the pure DNA analogue for a number of reasons. The joining reaction 
involving the DNA analogue requires high enzyme concentration and high 
acceptor to donor ratios unlike the joining reaction involving the 
composite oligonucleotide where relatively low enzyme concentrations 
and low acceptor to donor ratios are used.
The modification of the 3* end of oligonucleotides by the RNA llgase 
method has two advantages over the chemical method. First, the chemical 
method requires two separate reactions involving many chemicals and steps, 
whereas the RNA llgase method uses just one reaction. Secondly, chemical 
methods are not as clean as enzymatic ones. They produce more side 
reactions with modification of bases that can inhibit use with nucleic acid 
enzymes. The side products with modified bases are also difficult to remove 
using standard chromatographic techniques.
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